Dr Vijay Anand Reddy

Hospitals Contact

Dr Vijay Anand Reddy

Experience :
32 Years
Education :
H.O.D; MBBS; MD (Radiotherapy); DNB (Radiotherapy); Medical Oncology (ESMO); FUICC; FNDM; FUICC
Specialization :
Radiation Oncologist
Department :

Introduction

Dr. Reddy pursued his MBBS at Osmania Medical College, availing himself of a merit scholarship of One Thousand Rupees along with a state government aid of twenty-five Rupees per month for students from the agricultural background and aid from the Nizam’s Trust at Purdue Gate. He was elected Joint Secretary, OMC with a sweeping majority of 532 to 42 votes. In this capacity, he launched an active campaign against ragging. Post the Indo-Pakistan war of 1971, he along with his team raised funds of 5 lakh rupees across the twin cities of Hyderabad and Secunderabad for victims and refugees of the war. In 1977, he volunteered for relief work following the devastating floods that ravaged the state. In 1979, he was elected Secretary to Osmania Medical College. During his tenure, he was proactive in social work. Having passed his MBBS with flying colours, he started practising as First Medical Officer at Bhootpur Primary Health Centre. Thus began an illustrious journey which would culminate in his becoming a globally respected oncologist.

Fellowships and Memberships

  • Full Member of American Society of Clinical Oncology (ASCO)
  • Full Member of American Society for Radiation Oncology (ASTRO)
  • Permanent Member of European Society of Medical Oncology (ESMO)
  • Permanent Member of “Union for International Cancer Control”, UICC, Geneva
  • President of Association of Radiation Oncologists of India (AROI)
  • President of Association of Radiation Oncologists of India (AROI), Telangana Chapter
  • President of Association of Radiation Oncologists of India (AROI), AP Chapter (Past)
  • Member of Indian College of Radiation Oncology (ICRO)
  • Chairman, Indian College of Radiation Oncology (ICRO), INDIA
  • Member of Indian Society of Oncology (ISO)
  • Member of Civil Assistant Surgeon’s Association, Andhra Pradesh
  • Member of Indian Medical Association (IMA)
  • Member of Indian Co-operative Oncology Network (ICON)
  • Member of Indian Brachytherapy Society (IBS)

Awards and Achievements

Awards-Scientific Research:

  • Dr. Vijay Anand Reddy has been awarded as “The Legend in the Field of Oncology” at the Times Healthcare Achievers Awards function at HICC, Hyderabad on 28th Feb’ 2017.
  • "Best Scientific Paper Award 2015” for Prospective study of Neurocognitive function, performance status, quality of life and local control in patients with 1-3 newly diagnosed brain metastases treated with stereotactic radio surgery alone – Awarded by AROICON – 2015, Lucknow, INDIA
  • "Best Scientific Paper Award 2014” for A Prospective Observational Feasibility Study of Hypofractionated Radiotherapy for Clinically localized Carcinoma Prostate – Awarded by AROICON – 2014, Imphal, INDIA
  • American Academy of Ophthalmology Achievement Award
  • "Best Scientific Paper Award 2009” for Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors Awarded by AROICON – 2009, Hyderabad, INDIA
  • “Best Scientific Poster Award 2009” for Histopathology of Retinoblastoma after primary Chemotherapy Awarded by AROICON – 2009, Hyderabad, INDIA
  • “BEST POSTER” AWARD 2008 Awarded by American Academy of Ophthalmology at Atlanta, GA, USA
  • “YOUNG INVESTIGATORS AWARD” 2001 Awarded at New Delhi by Eli Lilly & Company, USA
  • “INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD”Awarded in 1998 by UICC, Geneva, Switzerland
  • “YOUNG SCIENTIST AWARD” 1996 Awarded by Indo-American Cancer Congress, New York, USA
  • “BEST SCIENTIFIC PAPER AWARD” 1996 at XVIII National Conference of Assoc. Oncologists of India” at Aurangabad
  • “NARGIS DUTT MEMORIAL FOUNDATION AWARD” 1995 Awarded by Nargis Dutt Memorial Foundation, Flushing, New York
  • “INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD”Awarded in 1992 by UICC, Geneva, Switzerland.


Presentations of Cancer:

  • Invited as a Panelist for the “Gynecological Session” at Best of ASCO – 2017, Chandigarh from July 14-16, 2017.
  • Invited as a Panelist for the “Lung Session” at Best of ASCO – 2017, Chandigarh from July 14-16, 2017.
  • Invited as a Chairperson for the Panel discussion on “Opening the Lid for Bevacizumab in Gynecological Malignancies” CME Organized by Intas Oncology, Hyderabad on July 12, 2017.
  • Invited as a Chairperson for the Session on “Expert talk in NSCLC” CME Organized by Novartis Oncology, Hyderabad on June 13, 2017.
  • “Radiotherapy in Retinoblastoma” at Retinoblastoma Networking Workshop, LVPEI, Hyderabad from June 10-12, 2017.
  • “Breast” at Best of ASTRO – 2017, Vizag on May 13-14, 2017.
  • “Bilateral Breast using TomoTherapy” at Accuray User’s Meeting, Bangalore on April 22-23, 2017.
  • “Re-irradiation – When and how to?” Session on “Novel therapies – Part III – Molecular Neuro-Oncology – Resistance and re-treatment” at 9th annual Conference of Indian Society of Neuro-Oncology (ISNOCON – 2017), Bangalore from January 10-12, 2017.
  • “Crossfire: Surgery vs Radiotherapy for high risk early Prostate Cancer” at First Prostate Cancer Symposium – PRiSM 2016 organized by Dr. Reddy’s Laboratories Ltd., Hyderabad from December 17-18, 2016.
  • “Optimal treatment for oligo brain metastasis: Role of SRS” Session on “CNS – Debate (Debator - 1 in favour of SRS)” at 39th AROICON – 2016, Bhubaneshwar from November 24-27, 2016.
  • “Plaque Brachytherapy for Ocular Tumor” Session on “Paediatrics Oncology” at 39th AROICON – 2016, Bhubaneshwar from November 24-27, 2016.
  • “Ocular Brachytherapy” at AROICON - 2016, TN-PY Chapter, Chennai on October 15-16, 2016.
  • “Cancer Management – Paradigm Shift” at Recent Advances in Surgical Procedures, Dubai – UAE on September 30, 2016.
  • “Organ Preservation Protocols – our experience” at FHNO South-East Zonal CME on Ca. Larynx, Organized by Apollo Cancer Institute in association with AOI – Hyderabad & Telangana State Branches, Hyderabad on September 3, 2016.
  • “Brachytherapy in Ophthalmic Tumors” at 6th Annual Conference of IBSCON – 2016, Hyatt Regency, Chennai on August 27-28, 2016.
  • “Radiotherapy in Elderly Breast Cancer” Session on “Breast Cancer in Elderly: Coming of Age” at Navigating Clinical Conundrums in Breast Cancer, Mumbai on August 20-21, 2016.
  • “Overall Scenario of Cancer in India & Prevention & Cure” Session on “Cancer Prevention & A Healthy Lifestyle” at CII Young Indians, Hyderabad on July 28, 2016.
  • Invited as a Perspective for “Hard Talk - Perspective in adopting new data” Session on “Irradiating the axilla- Why exchange one toxicity for another especially when prognostication is at stake?” at Controversies in Clinical Oncology, TMH, Kolkata from July 22-24, 2016.
  • “New Technology – Does it have an impact in the management of Gynaec Cancers – Cost vs benefit” at CME on “Oncology and Robotics in Gynecology”, organized by OGSH in association with Apollo Hospitals, Hyderabad on July 16, 2016.
  • Invited as a Panelist for the Panel discussion on “Case Based Discussion in Rare Solid Tumors” at 3rd Mid Term National Conference of Pediatric Hematology Oncology, Hyderabad on July 9-10, 2016.
  • “Role of Radiation Oncologist in the Management of Ophthalmic Tumors”, at EYE CANcer – 2016, LVPEI, Hyderabad on July 9, 2016.
  • Moderator for the Panel Discussion on “Lung Cancer – Non-small Cell / Small Cell / Other” at Best of ASCO – 2016, HICC, Hyderabad on July 1-3, 2016.
  • Moderator for the Session on “Each Expert Group Propose Recommendations” at CME on “Consensus Recommendations of Expert Group for Management of Advanced Cervical Cancer in India”, organized by Roche Oncology, Hyderabad on June 18, 2016.
  • “Cancer Management – A Paradigm Shift”, CME Program on Post Thrombotic Syndrome and Varicose Vein Ulcer Management organized by Apollo Hospitals, Hyderabad in association with IMA, East at Hyderabad on April 24, 2016.
  • Moderator for the Panel Discussion “Decision Making for Adjuvant Radiation” Session on “Breast Cancer 1: Early Breast Cancer” at 12th International Conference of Asian Clinical Oncology Society (ACOS), New Delhi from April 8-10, 2016.
  • Invited as a Chairperson for “Direction of Current Neuro-oncology Research” at ISNOCON – 2016, Hyderabad from April 1-3, 2016.
  • Invited as a Panelist for the ‘Head and Neck Cancer’ Session on “Therapeutic Decision Making in Borderline and locally advanced HNSCC” at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016.
  • Invited as a Panelist for the Lunch Symposium on “Challenges in delivery of chemoradiation in Lung Cancer” at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016.
  • “Did the higher accuracy in treatment delivery translate into noticeable Clinical Improvements?” at AROI – West Bengal Annual State Conference, Kolkata on February 20-21, 2016.
  • “Cancer Management – Paradigm Shift” at Indian Medical Association (IMA) CME, Hyderabad on February 13, 2016.
  • Invited as a Panelist for the Panel Discussion on “Nanotechnology based Paclitaxel in Clinical Practice” at SUN Oncology BEVETEX Symposium, Hyderabad on January 2, 2016.

Unique Contribution

Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-year Retrospective Study – Translational Vision Science & Technology, June 2017; Vol. 6; No. 3; Article 19; Pg. 1-9.
Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies using Whole body Nuclear Scintigraphy and SPECT-CT – The American Society of Ophthalmic Plastic and Reconstructive Surgery 2014; Vol. XX; No. XX; Pg. 1-4.
Ophthalmologic Pathology: SY20-2 What is your Diagnosis? – Royal College of Pathologists of Australia, Taylor & Francis October 2014; Vol. 46 (2); Pg. S30
Orbital Alveolar soft-part Sarcoma: Clinico-pathological profiles, management and Outcomes – Journal of Cancer Research and Therapeutics; April-June 2014; Vol. 10; Issue. 2; Pg. 294-298.
Management and Outcome of Retinoblastoma with Vitreous Seeds – American Academy of Ophthalmology Feb 2014; Vol. 121 (2); Pg. 517-524
Lacrimal Surgery Glorious past, exciting present era and the audacity of hope for a brilliant future – Saudi Journal of Ophthalmology 2014; Vol. 28; Pg. 1-2.
Distant metastatic Retinoblastoma without Central Nervous system involvement – Indian Journal of Ophthalmology July 2013; Vol. 61(7); Pg. 357-359.
Primary Intraocular Malignant Extrarenal Rhabdoid tumor: a Clinicpathological Correlation – Journal of Pediatric Ophthalmology and Strabismus April 2013; Vol. 50; Pg. e18-20.
Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker – Histopathology May 2013; Vol. 62(6); Pg. 840-846.
Distant Metastatic Retinoblastoma without Central Nervous System involvement – Indian Journal of Ophthalmology April 2013; PubMed ID - 23548316.
Optic Nerve Meningeal Hemangiopericytoma: A Clinicopathological Case Report – Survey of Ophthalmology January 2013; pii: S0039-6257(12)00248-2. doi: 10.1016; PubMed ID – 23294915.
Radiation Oncology in 21st Century – Changing the Paradigms – Apollo Medicine June 2012; Vol. 9; No. 2; Pg. 115-125.
Orbital Plasmablastic Lymphoma: A Clinico-Pathological Correlation of a rare disease and review of Literature - Clinical Ophthalmology (Auckland, N.Z.) 6: 2012; Pg. 2049-2057.
Evaluation of HER-2/neu status in Breast Cancer Specimens using Immunohistochemistry (IHC) & Fluorescence in-situ hybridization (FISH) assay – Indian Journal of Medical Research March 2012; Pg. 312-317.
Establishing Human Lacrimal Gland Cultures with Secretory Function - PLoS One. 2012; Vol. 7(1); e29458.
High Dose Rate Interstitial Brachytherapy in Carcinoma Eyelid: Can it be a Primary treatment Modality? – Journal of Cancer Research and Therapeutics Oct-Dec 2011; Vol. 7(4); Pg. 498-499.
First Indian Experience with Shaped Beam Radiosurgery of Cranial and Spinal Lesions on Novalis-Tx Linear Accelerator with Exac Trac 6D Robotic Couch – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1166.
Set-up Accuracy with Frameless Radiosurgery of Intracranial Lesions using Exac Trac 6-D Robotic Couch on Novali-Tx Linear Accelerator – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1147.
Comparison of Intensity Modulated Stereotactic Radiosurgery with Conventional Stereotactic Conformal Beam Radiosurgery in Vestibular Schwannomas – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1003.
The New Radiation Technology and Techniques – Does it Matter in Gynec Cancer? – Annals of IMA Academy of Medical Specialities 2011; Pg. 49-53.
Evaluation of Human Lacrimal Gland Cultures for Secretory Function and Putative Stem Cells – Indian Eye Research Group (IEGR) 2011; Pg. 84.
Orbital Retinoblastoma: Where do we go from here? – Journal of Cancer Research and Therapeutics May 2011; Vol. 7(1); Pg. 11-14.
Cultivation and Characterization of Human Lacrimal Gland Cells for Potential Clinical Application – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 80.
Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 110-111.
Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Shifting Paradigms in Head and Neck Oncology (IFHNOS) 2010; Vol. 1; Pg. 233
Orbital Retinoblastoma: Present status and future challenges – A review – Saudi Journal of Ophthalmology 2010, Vol. 25(2); Pg. 159-167.
Largest series of orbital Schwannoma: Clinical manifestations and outcomes (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 131.
Genotype-Phenotype and Clinical correlation in Retinoblastoma (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 129.
RBI Gene Mutations in Ratinoblastoma and its clinical correlation – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 119-123.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 121.
A typical presentation of Ciliary body Medulloepithelioma (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 116.
Histopathology of Retinoblastoma after primary Chemotherapy (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 100.
Evisceration in unsuspected Intraocular Tumors - Archives of Ophthalmology March 2010; Vol. 128(3); Pg. 372-379.
Histopathologic changes in Uveal melanoma after Ruthenium 106 Brachytherapy – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
Cultivation and characterization of Lacrimal and Salivary Gland Cells for Potential Clinical application – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
Role of HPV, Cell cycle markers and epigenetic modifications at DNMT3L region in Ocular surface Squamous Neoplasia – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
HPV for Cervical Cancer Screening: Is the era of the Molecular Pap Smear upon us? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
Ruthenium 106 Plaque Brachytherapy : Indications and outcome in Ocular Tumors – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S88
Cervical Cancer Screening: Role of Serotyping of HPV as bridge of Cytopathology and Molecular typing? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
Genotype and phenotype correlation analysis in Retinoblastoma – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
Sebaceous Carcinoma of the Eyelid Metastasizing to the Lacrimal Sac after 5 years – Orbit (Amsterdam, Netherlands) October 2009; Vol. 28(5); Pg.309-312.
Histopathology of retinoblastoma after primary chemotherapy – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 296.
Orbital Schwannoma: Clinical manifestations and outcomes – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 146.
A typical presentation of Ciliary body Medulloepithelioma – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 46.
Histopathologic risk factors in Retinoblastoma in India - Archives of Pathology & Laboratory Medicine August 2009; Vol. 133(8); Pg. 1210-1214.
Extramedullary Leukemia in Children presenting with Proptosis – Journal of Hematology & Oncology 2009; Vol. 2; Pg. 4.
Retinoblastoma – Advances in Management – Apollo Medicine Sept. 2008; Vol. 5; No. 3; Pg. 183-189.
Proptosis as a Manifestation of Acute Myeloid Leukemia – Pediatric Clinics of North India 2008.
Metastasis to the Eye and Orbit from Renal Cell Carcinoma – A Report of Three Cases and Review of Literature - Survey of Ophthalmology Mar-Apr 2007; Vol. 52(2); Pg. 213-223.
Systemic Metastasis Following Hyphema Drainage in an Unsuspected Retinoblastoma – Journal of Pediatric Ophthalmology and Strabismus Mar-Apr 2007; Vol. 44; Pg. 120-123.
Orbital Embryonal Rhabdomyosarcoma in association with Neurofibromatosis type 1 – Ophthalmic Plastic and Reconstructive Surgery Mar-Apr 2007; Vol. 23(2); Pg. 147-148.
Acute Respiratory Distress Syndrome due to Strongyloides Stercoralis in Non-Hodgkin's Lymphoma – The Indian Journal of Chest Diseases & Allied Sciences Jan-Mar 2006; Vol. 48(1); Pg. 67-69.
Ruthenium-106 Plaque Brachytherapy for the treatment of Diffuse Choroidal Haemangioma in Sturge-Weber Syndrome - Indian Journal of Ophthalmology Dec. 2005; Vol. 53(4); Pg. 274-275.
Neoadjuvant Chemotherapy in the Management of Sebaceous Gland Carcinoma of the Eyelid with Regional Lymph Node Metastasis - Ophthalmic Plastic and Reconstructive Surgery July 2005; Vol. 21(4); Pg. 307-309.
Concurrent Chemo Radiotherapy followed by Intraluminal Brachytherapy in non-metastatic carcinoma oesophagus – Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, Vol. 22, 14S (July 15 Supplement), 2004 : 4201.
Clinicopathologic findings in Choroidal Melanomas after failed Transpupillary Thermotherapy - American Journal of Ophthalmology March 2004; Vol. 137(3); Pg. 594-595; author reply 595-596
Histopathology of Retinoblastoma after Primary Chemotherapy – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 94.
Cancer Awareness L

Add new review for Dr Vijay Anand Reddy